TATE Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Cross Selling SuccessTate & Lyle states that it is seeing initial cross selling success with the pipeline having more than doubled over the last 2 months.
Future EBITDA RecoveryThe expected recovery of adjusted EBITDA back to pro forma FY25 levels is anticipated after a decline.
Revenue SynergiesThe CP Kelco acquisition should provide future revenue synergies, enhancing the company's financial performance.
Bears Say
Guidance DowngradeThe delta of the downgrade to the guidance is more significant than peers, and hence the shares are expected to underperform the sector and overall track lower.
Market Demand ChallengesTate & Lyle is navigating a challenging period driven by weak demand, marked by cumulative organic volume declines since FY23.
Market Demand SlowdownTate & Lyle states that it has observed a slowdown in market demand which has affected recent performance and hence is reducing the 1H25/26 outlook and FY25/26 guidance.
Tate & Lyle News
TATE FAQ
What was Tate & Lyle Plc’s price range in the past 12 months?
Currently, no data Available
What is Tate & Lyle Plc’s market cap?
Tate & Lyle Plc’s market cap is £2.45B.
When is Tate & Lyle Plc’s upcoming earnings report date?
Tate & Lyle Plc’s upcoming earnings report date is Nov 05, 2026 which is in 127 days.
How were Tate & Lyle Plc’s earnings last quarter?
Tate & Lyle Plc released its earnings results on May 21, 2026. The company reported $0.192 earnings per share for the quarter, beating the consensus estimate of $0.155 by $0.037.
Is Tate & Lyle Plc overvalued?
According to Wall Street analysts Tate & Lyle Plc’s price is currently Undervalued.
Does Tate & Lyle Plc pay dividends?
Tate & Lyle Plc does not currently pay dividends.
What is Tate & Lyle Plc’s EPS estimate?
Tate & Lyle Plc’s EPS estimate is 0.21.
How many shares outstanding does Tate & Lyle Plc have?
Currently, no data Available
What happened to Tate & Lyle Plc’s price movement after its last earnings report?
Tate & Lyle Plc reported an EPS of $0.192 in its last earnings report, beating expectations of $0.155. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tate & Lyle Plc?
Currently, no hedge funds are holding shares in CH:TATE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tate & Lyle Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£531.83 (― Downside)
£531.83 (― Downside)
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.85%
12-Months-Change
Fundamentals
Return on Equity
6.17%
Trailing 12-Months
Asset Growth
-1.74%
Trailing 12-Months
Company Description
Tate & Lyle Plc
Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.
TATE Stock 12 Month Forecast
Average Price Target
$531.83
Options Prices
Currently, No data available
---